250 molecole in sviluppo per l'Hiv

Oltre 250 molecole sono in svilippo nel mondo, a vari stadi della ricerca, per l'hiv.
E' quanto emerge da questo interessante articolo:
[Devi essere iscritto e connesso per vedere questo link]

HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016

The report identifies the key trends shaping and driving the global HIV/AIDS market.

Dallas, TX -- (SBWIRE) -- 01/17/2011 -- GlobalData's report, “HIV/AIDS – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global HIV/AIDS sector. GlobalData estimated the HIV/AIDS market was worth $12 billion in 2009. The global Human Immunodeficiency Virus (HIV) infection market will continue to grow between 2009 and 2016 at a slower rate due to a series of patent expiries during this period. The growth rate is likely to decline from 2012 onwards due to the impact of the patent expiry of key drugs. The market is characterized by a high unmet need of drugs which can cure the disease. Highly Active Antiretroviral Therapy (HAART) which requires patients to take different classes of drugs has however succeeded in achieving near zero levels of HIV in infected people. Increased uptake of HAART and increasing awareness (which leads to increased treatment seeking) will drive the market. The pipeline for HIV is strong and consists of more than 250 molecules currently in development for various disease segments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Scope

Annualized global HIV/AIDS market revenues data from 2001 to 2009, forecast for seven years to 2016.

Geographies covered in this report are the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan.

Pipeline analysis data providing a split across phases by mechanism of action, and the emerging trends. The key classes of mechanism of action include HIV vaccines, Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs), Protease Inhibitors (PIs), Multi-class Combination Products, Nucleoside Reverse Transcriptase Inhibitors (NRTIs), CCR5 receptor antagonists, HIV integrase inhibitors, Nucleoside analogues, Viral entry inhibitors, Maturation inhibitors and Fusion Inhibitors.

Analysis of the current and future market competition in the global HIV/AIDS market. The key market players covered Boehring Ingelheim, Achillion Pharmaceuticals, GlaxoSmithKline, Incyte and Pharmasset, Shire Pharmaceuticals and Tibotec Virco

Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
The key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future HIV/AIDS market.
Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:

Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.

Develop business strategies by understanding the trends shaping and driving the global HIV/AIDS market.

Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global HIV/AIDS market in future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

What’s the next big thing in the global HIV/AIDS market landscape? – Identify, understand and capitalize.

Buy Now : Market Research
[Devi essere iscritto e connesso per vedere questo link]

Related Reports

HIV-AIDS – Pipeline Assessment and Market Forecasts to 2016

The HIV/AIDS Market Outlook to 2015: Competitive landscape, market size, pipeline analysis and growth opportunities

Head and Neck Cancer - Drug Pipeline Analysis and Market Forecasts to 2016

Amyotrophic Lateral Sclerosis (Lou Gehrig's) - Drug Pipeline Analysis and Market Forecasts to 2016

Erectile Dysfunction - Drug Pipeline Analysis and Market Forecasts to 2016

Tuberculosis - Drug Pipeline Analysis and Market Forecasts to 2016

Hepatitis B - Drug Pipeline Analysis and Market Forecasts to 2016

Candidiasis - Drug Pipeline Analysis and Market Forecasts to 2016

Acne - Drug Pipeline Analysis and Market Forecasts to 2016

Herpes Simplex - Drug Pipeline Analysis and Market Forecasts to 2016

HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016

About Us:
ReportsnReports comprises of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.